tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PBYI Stock Latest News

FDA allows Puma to proceed under IND with alisertib development for BC
The FlyFDA allows Puma to proceed under IND with alisertib development for BC
1M ago
PBYI
Puma Biotechnology says court denied AstraZeneca’s motion for invalidity
PremiumThe Fly
Puma Biotechnology says court denied AstraZeneca’s motion for invalidity
1M ago
AZN
PFE
Puma Biotechnology price target lowered to $7 from $8 at H.C. Wainwright
PremiumThe Fly
Puma Biotechnology price target lowered to $7 from $8 at H.C. Wainwright
2M ago
PBYI
Puma Biotechnology sees Fy24 revenue $214M-$225M, consensus $244.7M
PremiumThe Fly
Puma Biotechnology sees Fy24 revenue $214M-$225M, consensus $244.7M
2M ago
PBYI
Puma Biotechnology sees Q1 revenue $40.5M-$43M, one estimate 56.5M
PremiumThe Fly
Puma Biotechnology sees Q1 revenue $40.5M-$43M, one estimate 56.5M
2M ago
PBYI
Puma Biotechnology reports Q4 EPS 31c, consensus 30c
PremiumThe FlyPuma Biotechnology reports Q4 EPS 31c, consensus 30c
2M ago
PBYI
PBYI Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PBYI Upcoming Earnings Report: What to Expect?
2M ago
PBYI
Puma inititates ALISCA-Lung1 Phase II trial of Alisertib in SCLC
PremiumThe Fly
Puma inititates ALISCA-Lung1 Phase II trial of Alisertib in SCLC
2M ago
PBYI
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
MOR
ALLK
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
MOR
ALLK
Puma Biotechnology announces design of alisertib trial
PremiumThe Fly
Puma Biotechnology announces design of alisertib trial
5M ago
PBYI
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
ACRS
CRMD
Puma Biotechnology sees Q4 product revenue $56M-$59M
PremiumThe FlyPuma Biotechnology sees Q4 product revenue $56M-$59M
6M ago
PBYI
Puma Biotechnology reports Q3 EPS 17c, consensus 8c
PremiumThe Fly
Puma Biotechnology reports Q3 EPS 17c, consensus 8c
6M ago
PBYI
Puma presents findings from Phase I/II study of alisertib, pembrolizumab
PremiumThe Fly
Puma presents findings from Phase I/II study of alisertib, pembrolizumab
6M ago
PBYI
Puma Biotechnology receives FDA orphan drug designation for Alisertib
PremiumThe Fly
Puma Biotechnology receives FDA orphan drug designation for Alisertib
7M ago
PBYI
Puma Biotechnology’s alisertib granted orphan designation by FDA
PremiumThe Fly
Puma Biotechnology’s alisertib granted orphan designation by FDA
7M ago
PBYI
Puma Biotechnology announces FDA clearance for alisertib IND
PremiumThe Fly
Puma Biotechnology announces FDA clearance for alisertib IND
9M ago
PBYI
Puma Biotechnology sees FY23 revenue $230M-$240M, consensus $232.3M
PremiumThe Fly
Puma Biotechnology sees FY23 revenue $230M-$240M, consensus $232.3M
9M ago
PBYI
Puma Biotechnology sees Q3 revenue $54M-$58M, consensus $60.5M
PremiumThe FlyPuma Biotechnology sees Q3 revenue $54M-$58M, consensus $60.5M
9M ago
PBYI
Puma Biotechnology reports Q2 EPS 10c, consensus 1c
PremiumThe Fly
Puma Biotechnology reports Q2 EPS 10c, consensus 1c
9M ago
PBYI
PBYI Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PBYI Upcoming Earnings Report: What to Expect?
12M ago
PBYI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >